285 results on '"Puhan, Milo A."'
Search Results
2. Surgical Outcome Reporting. Moving From a Comic to a Tragic Opera?
- Author
-
Abbassi, Fariba, Pfister, Matthias, Domenghino, Anja, Puhan, Milo A., and Clavien, Pierre-Alain
- Published
- 2024
- Full Text
- View/download PDF
3. Effects of Pycnogenol® in people with post-COVID-19 condition (PYCNOVID): study protocol for a single-center, placebo controlled, quadruple-blind, randomized trial.
- Author
-
Radtke, Thomas, Künzi, Lisa, Kopp, Julia, Rasi, Manuela, Braun, Julia, Zens, Kyra D., Winter, Babette, Anagnostopoulos, Alexia, Puhan, Milo A., and Fehr, Jan S.
- Subjects
SARS-CoV-2 ,COVID-19 pandemic ,COVID-19 ,PHYSICAL activity - Abstract
Background: A significant proportion of the global population has been infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) at some point since the onset of the pandemic. Although most individuals who develop coronavirus disease 2019 (COVID-19) recover without complications, about 6% have persistent symptoms, referred to as post-COVID-19 condition (PCC). Intervention studies investigating treatments that potentially alleviate PCC-related symptoms and thus aim to mitigate the global public health burden and healthcare costs linked to PCC are desperately needed. The PYCNOVID trial investigates the effects of Pycnogenol®, a French maritime pine bark extract with anti-inflammatory and antioxidative properties, versus placebo on patient-reported health status in people with PCC. Methods: This is a single-center, placebo-controlled, quadruple blind, randomized trial. We aim to randomly assign 150 individuals with PCC (1:1 ratio) to receive either 200 mg Pycnogenol® or placebo daily for 12 weeks. Randomization is stratified for duration of PCC symptoms (≤ 6 months versus > 6 months) and presence of symptomatic chronic disease(s). The primary endpoint is perceived health status at 12 weeks (EuroQol—Visual Analogue Scale) adjusted for baseline values and stratification factors. Secondary endpoints include change in self-reported PCC symptoms, health-related quality of life, symptoms of depression and anxiety, cognitive function, functional exercise capacity, physical activity measured with accelerometry, and blood biomarkers for endothelial health, inflammation, coagulation, platelet function, and oxidative stress. Investigators, study participants, outcome assessors, and data analysts are blinded regarding the intervention assignment. Individuals with PCC were involved in the design of this study. Discussion: This is the first trial to investigate the effects of Pycnogenol® versus placebo on patient-reported health status in people with PCC. Should the trial proof clinical effectiveness, Pycnogenol® may serve as a therapeutic approach to mitigate symptoms associated with PCC. Trial registration: The study is registered at ClinicalTrials.gov. :NCT05890534, June 6, 2023. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Predictors of work inability after acute myocardial infarction in Switzerland.
- Author
-
Barresi, Fabio, Foster-Witassek, Fabienne, Rickli, Hans, Pedrazzini, Giovanni, Roffi, Marco, Puhan, Milo, Dressel, Holger, and Radovanovic, Dragana
- Subjects
MYOCARDIAL infarction ,WORKING hours ,LOGISTIC regression analysis - Abstract
This study aimed to examine whether acute myocardial infarction (AMI) patients in Switzerland return to work and identify factors associated therewith. Data of 4315 working-age AMI patients enrolled in the Swiss AMIS Plus registry between 01/2006 and 09/2021 with 1-year follow-up and self-reported work status were analyzed. Patient characteristics were compared between those who did not reduce their work hours, those who reduced, and those who were no longer working 1 year after AMI. Multinomial logistic regression was used to analyze independent predictors of working ability. Of the patients, 3204 (74.3%) did not reduce their work hours, 592 (13.7%) reduced and 519 (12.0%) were no longer working 1 year after AMI. Women were more likely to reduce or stop working. Patients who did not reduce were more frequently young and male. Multinomial logistic regression showed that work reduction was associated with female sex and a Killip class > 2 at admission whereas stopping work was associated with female sex and comorbidities. A high rate of AMI patients in Switzerland (88%) return to work 1 year after AMI. Approximately 1 in 8 did not return to work and approximately 1 in 7 reduced their work hours. Important factors associated with reducing or no longer working after AMI were female sex, older age and a higher proportion of comorbidities. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Evidence-based coaching of core competencies in epidemiology, using the framework of randomized controlled trials: the Zurich approach.
- Author
-
Radtke, Thomas, Wyl, Viktor von, Haile, Sarah R, Rohrmann, Sabine, Frei, Anja, and Puhan, Milo A
- Subjects
RANDOMIZED controlled trials ,CORE competencies ,LIFE cycles (Biology) ,TEACHING methods ,SELF-contained classrooms ,EPIDEMIOLOGICAL transition - Abstract
Teaching epidemiological concepts in academic settings poses a challenge due to the intricate nature of the discipline as both a science and a practice. Whereas traditional classroom-based teaching methods are commonly employed, evidence suggests they may not be the most effective approach for fostering core competencies and skills required in real-life scientific work. In this article, we describe our process of transitioning from traditional classroom teaching of epidemiology towards practice-based coaching to convey epidemiological concepts to bachelor's and master's students in Biomedicine. We chose the framework of randomized controlled trials (RCT) since they offer a great opportunity to teach epidemiological concepts in a hands-on course. This practice-based course encompasses the entire life cycle of a study, allowing students to design and conduct a short-term experiment, analyse its data and prepare a scientific paper. We provide a comprehensive overview of the course structure, content, learning objectives and course evaluation, while also discussing the advantages and disadvantages of this innovative format. Our approach offers a promising alternative to classroom teaching by incorporating practical, hands-on experiences offering students a high level of independence and self-determination, as well as facilitation and coaching by faculty. It has the potential to be applied across diverse academic settings, providing students with valuable skills and competencies in epidemiology. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
6. Swiss chiropractic cohort (Swiss ChiCo) pilot study: feasibility for a musculoskeletal cohort study conducted within a nationwide practice-based research network.
- Author
-
Lalji, Rahim, Hofstetter, Léonie, Kongsted, Alice, von Wyl, Viktor, Braun, Julia, Puhan, Milo A., Hincapié, Cesar A., Bidlingmeyer, Aline, Fingal, Andreas, Maire, Anja, Gassner, Antonia, Kurmann, Astrid, Pulver, Bernhard, Beetschen, Carole, Chervet, Christian, Padua, Christina, Schmid, Christof, Noirat-Berdat, Clarisse, Illi, Claude, and Faas, Colette
- Subjects
CHIROPRACTIC ,PILOT projects ,FEASIBILITY studies ,COHORT analysis ,MUSCULOSKELETAL pain - Abstract
Purpose: Practice-based research networks are collaborations between clinicians and researchers to advance primary care research. This study aims to assess the feasibility for longitudinal data collection within a newly established chiropractic PBRN in Switzerland. Methods: A prospective observational cohort feasibility study was performed. PBRN participating chiropractors were asked to recruit patients seeking new conservative health care for musculoskeletal pain from March 28, 2022, to September 28, 2022. Participants completed clinically oriented survey questions and patient-reported outcome measures before the initial chiropractic assessment as well as 1 h, 2 weeks, 6 weeks, and 12 weeks thereafter. Feasibility was assessed through a variety of process, resource, and management metrics. Patient clinical outcomes were also assessed. Results: A total of 76 clinicians from 35 unique primary care chiropractic clinics across Switzerland participated. A total of 1431 patients were invited to participate, of which 573 (mean age 47 years, 51% female) were enrolled. Patient survey response proportions were 76%, 64%, 61%, and 56%, at the 1-h, 2-, 6-, and 12-week survey follow-ups, respectively. Evidence of an association was found between increased patient age (OR = 1.03, 95%CI 1.01–1.04), patient from a German-speaking region (OR = 1.81, 95%CI 1.17–2.86), non-smokers (OR = 1.89, 95%CI 1.13–3.17), and increased pain impact score at baseline (OR = 1.18, 95%CI 1.01–1.38) and response to all surveys. Conclusion: The Swiss ChiCo pilot study exceeded its prespecified feasibility objectives. Nationwide longitudinal data capture was highly feasible. Similar to other practice-based cohorts, participant retention remains a challenge. Trial registration Swiss chiropractic cohort (Swiss ChiCo) pilot study (ClinicalTrials.gov identifier: NCT05116020). [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
7. Feasibility of blinding spinal manual therapy interventions among participants and outcome assessors: protocol for a blinding feasibility trial.
- Author
-
Muñoz Laguna, Javier, Kurmann, Astrid, Hofstetter, Léonie, Nyantakyi, Emanuela, Clack, Lauren, Bang, Heejung, Foster, Nadine E., Braun, Julia, Puhan, Milo A., Farshad, Mazda, and Hincapié, Cesar A.
- Subjects
PAIN perception ,LUMBAR pain ,APPRAISERS ,RANDOMIZED controlled trials ,LUMBAR vertebrae ,BACKACHE ,OLANZAPINE - Abstract
Introduction: Blinding is a methodologically important aspect in randomised controlled trials yet frequently overlooked in trials of spinal manual therapy interventions for back pain. To help inform the blinding methods of a future, double-placebo-controlled trial comparing spinal manual therapy and nerve root injection for lumbosacral radicular pain, we set four objectives: (1) to assess the feasibility of blinding participants, randomly allocated to an active or placebo-control spinal manual therapy intervention protocol, (2) to assess the feasibility of blinding outcome assessors within the trial, (3) to explore the influence of spinal manual therapy experience and low back pain on blinding, and (4) to explore factors contributing to perceptions about intervention assignment among participants and outcome assessors. Methods and analysis: Two-parallel-group, single-centre, placebo-controlled, methodological blinding feasibility randomised trial. We will recruit between 60 and 100 adults with or without back pain and with or without experience of spinal manual therapy from Zurich, Switzerland. Participants will be randomised to either an active spinal manual therapy or a placebo-control spinal manual therapy protocol—both interventions delivered over two study visits, up to two weeks apart. The primary outcome is participant blinding using the Bang blinding index within each intervention arm immediately after each of the two study visits. Secondary outcomes are participant blinding using the James blinding index, outcome assessor blinding (Bang and James blinding indices), self-reported factors influencing perceived intervention assignment among participants and outcome assessors, and participant-reported credibility and expectancy of study interventions. Other outcomes—included to blind the study objective from participants—are lumbar spine range of motion, self-rated general health, satisfaction with care, pain intensity, and function. Intervention provider outcomes include intervention component fidelity and quality of intervention delivery. Ethics and dissemination: The independent ethics commission of Canton Zurich granted ethical approval for this study (KEK 2023–00381). Written informed consent will be obtained from all participants. Findings will be disseminated in scientific conferences and a peer-reviewed publication and inform the blinding methods of a future double-placebo controlled trial comparing spinal manual therapy and nerve root injection for lumbosacral radicular pain—the SALuBRITY trial. Trial registration: NCT05778396. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
8. Determinants of health-related quality of life in healthy children and adolescents during the COVID-19 pandemic: Results from a prospective longitudinal cohort study.
- Author
-
Haile, Sarah R., Peralta, Gabriela P., Raineri, Alessia, Rueegg, Sonja, Ulytė, Agnė, Puhan, Milo A., Radtke, Thomas, and Kriemler, Susi
- Subjects
QUALITY of life ,COVID-19 pandemic ,COHORT analysis ,SCREEN time ,TEENAGERS - Abstract
Understanding health-related quality of life (HRQOL) in children and adolescents, during a pandemic and afterwards, aids in understanding how circumstances in their lives impact their well-being. We aimed to identify determinants of HRQOL from a broad range of biological, psychological, and social factors in a large longitudinal population-based sample. Data was taken from a longitudinal sample (n = 1843) of children and adolescents enrolled in the prospective school-based cohort study Ciao Corona in Switzerland. The primary outcome was HRQOL, assessed using the KINDL total score and its subscales (each from 0, worst, to 100, best). Potential determinants, including biological (physical activity, screen time, sleep, etc.), psychological (sadness, anxiousness, stress), and social (nationality, parents' education, etc.) factors, were assessed in 2020 and 2021 and HRQOL in 2022. Determinants were identified in a data-driven manner using recursive partitioning to define homogeneous subgroups, stratified by school level. Median KINDL total score in the empirically identified subgroups ranged from 68 to 83 in primary school children and from 69 to 82 in adolescents in secondary school. The psychological factors sadness, anxiousness, and stress in 2021 were identified as the most important determinants of HRQOL in both primary and secondary school children. Other factors, such as physical activity, screen time, chronic health conditions, or nationality, were determinants only in individual subscales. Conclusion: Recent mental health, more than biological, physical, or social factors, played a key role in determining HRQOL in children and adolescents during pandemic times. Public health strategies to improve mental health may therefore be effective in improving HRQOL in this age group. What is Known: • Assessing health-related quality of life (HRQOL) in children and adolescents aids in understanding how life circumstances impact their well-being. • HRQOL is a complex construct, involving biological, psychological, and social factors. Factors driving HRQOL in children and adolescents are not often studied in longitudinal population-based samples. What is New: • Mental health (stress, anxiousness, sadness) played a key role in determining HRQOL during the coronavirus pandemic, more than biological or social factors. • Public health strategies to improve mental health may be effective in improving HRQOL in children. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
9. An Unwanted but Long-Known Company: Post-Viral Symptoms in the Context of Past Pandemics in Switzerland (and Beyond).
- Author
-
Staub, Kaspar, Ballouz, Tala, and Puhan, Milo
- Subjects
PANDEMICS ,POST-acute COVID-19 syndrome ,SARS-CoV-2 ,VIRUS diseases ,SYMPTOMS - Abstract
Objectives: Some people do not fully recover from an acute viral infection and experience persistent symptoms or incomplete recovery for months or even years. This is not unique to the SARS-CoV-2 virus and history shows that post-viral conditions like post COVID-19 condition, also referred to as Long Covid, are not new. In particular, during and after pandemics caused by respiratory viruses in which large parts of the population were infected or exposed, professional and public attention was increased, not least because of the large number of people affected. Methods: Given the current relevance of the topic, this article aims to narratively review and summarize the literature on post-viral symptoms during past pandemics and to supplement and illustrate it with Swiss examples from the pandemics of 1890, 1918-1920 and later. Results: Post-viral diseases were an increasingly emphasised health topic during and after past pandemics triggered by respiratory infections over the last 150 years. Conclusion: In the next pandemic, it should not be surprising that post-viral conditions will again play a role, and pandemic plans should reflect this. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
10. Emerging Health Care Leaders: Lessons From a Novel Leadership and Community-Building Program.
- Author
-
Martani, Andrea, Ulyte, Agne, Menges, Dominik, Reeves, Emily, Puhan, Milo A., and Heusser, Rolf
- Subjects
PUBLIC health education ,MEDICAL care ,HEALTH care reform ,LEADERSHIP ,TRANSFORMATIVE learning - Abstract
Background: Although there are guidelines and ideas on how to improve public health education, translating innovative approaches into actual training programs remains challenging. In this article, we provide an overview of some initiatives that tried to put this into action in different parts of the world, and present the Emerging Health Care Leader (EHCL), a novel training program developed in Switzerland. Policy Options and Recommendations: Looking at the experience of the EHCL, we propose policymakers and other interested stakeholders who wish to help reform public health education to support these initiatives not only through funding, but by valuing them through the integration of early career healthcare leaders in projects where their developing expertise can be practically applied. Conclusion: By openly sharing the experiences, strengths, weaknesses, and lessons learned with the EHCL program, we aim to foster a transparent debate on how novel training programs in public health can be organised. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
11. A guide for a student-led doctoral-level qualitative methods short course in epidemiology: faculty and student perspectives.
- Author
-
Gille, Felix, Frei, Anja, Kaufmann, Marco, Lehmann, Anja, Laguna, Javier Muñoz, Papadopoulos, Kimon, Spörri, Angela, Stanikić, Mina, Tušl, Martin, Zavattaro, Federica, and Puhan, Milo Alan
- Abstract
Qualitative research and mixed methods are core competencies for epidemiologists. In response to the shortage of guidance on graduate course development, we wrote a course development guide aimed at faculty and students designing similar courses in epidemiology curricula. The guide combines established educational theory with faculty and student experiences from a recent introductory course for epidemiology and biostatistics doctoral students at the University of Zurich and Swiss Federal Institute of Technology, Zurich. We propose a student-centred course with inverse classroom teaching and practice exercises with faculty input. Integration of student input during the course development process helps align the course syllabus with student needs. The proposed course comprises six sessions that cover learning outcomes in comprehension, knowledge, application, analysis, synthesis and evaluation. Following an introductory session, the students engage in face-to-face interviews, focus group interviews, observational methods, analysis and how qualitative and quantitative methods are integrated in mixed methods. Furthermore, the course covers interviewer safety, research ethics, quality in qualitative research and a practice session focused on the use of interview hardware, including video and audio recorders. The student-led teaching characteristic of the course allows for an immersive and reflective teaching-learning environment. After implementation of the course and learning from faculty and student perspectives, we propose these additional foci: a student project to apply learned knowledge to a case study; integration in mixed-methods; and providing faculty a larger space to cover theory and field anecdotes. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
12. A New Model for Ranking Schools of Public Health: The Public Health Academic Ranking.
- Author
-
Dugerdil, Adeline, Babington-Ashaye, Awa, Bochud, Murielle, Margaret Chan, Chiolero, Arnaud, Gerber-Grote, Andreas, Künzli, Nino, Paradis, Gilles, Puhan, Milo Alan, Suggs, L. Suzanne, Van der Horst, Klazine, Escher, Gérard, and Flahault, Antoine
- Subjects
SCHOOL rankings ,PUBLIC schools ,PUBLIC health ,BIBLIOTHERAPY ,UNIVERSITY rankings ,TROPICAL medicine ,WEB analytics ,SOCIAL indicators - Abstract
Objectives: As there is no ranking designed for schools of Public Health, the aim of this project was to create one. Methods: To design the Public Health Academic Ranking (PHAR), we used the InCites Benchmarking and Analytics™ software and the Web Of Science™ Core Collection database. We collected bibliometric data on 26 schools of Public Health from each continent, between August and September 2022. We included 11 research indicators/ scores, covering four criteria (productivity, quality, accessibility for readers, international collaboration), for the period 2017–2021. For the Swiss School of Public Health (SSPH+), a network gathering faculties across different universities, a specific methodology was used, with member-specific research queries. Results: The five top schools of the PHAR were: London School of Hygiene and Tropical Medicine, Public Health Foundation of India, Harvard T.H. Chan School of Public Health, SSPH+, Johns Hopkins Bloomberg School of Public Health. Conclusion: The PHAR allows worldwide bibliometric ordering of schools of Public Health. As this is a pilot project, the results must be taken with caution. This article aims to critically discuss its methodology and future improvements. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
13. Lung Cancer in Switzerland.
- Author
-
Werner, Raphael Sven, Curioni-Fontecedro, Alessandra, Mauti, Laetitia A., Addeo, Alfredo, Peters, Solange, Frauenfelder, Thomas, Puhan, Milo A., Haberecker, Martina, Bubendorf, Lukas, Finazzi, Tobias, Guckenberger, Matthias, Cafarotti, Stefano, Geiser, Thomas, and Opitz, Isabelle
- Published
- 2024
- Full Text
- View/download PDF
14. Real-world walking cadence in people with COPD.
- Author
-
Delgado-Ortiz, Laura, Ranciati, Saverio, Arbillaga-Etxarri, Ane, Balcells, Eva, Buekers, Joren, Demeyer, Heleen, Frei, Anja, Gimeno-Santos, Elena, Hopkinson, Nicholas S., de Jong, Corina, Karlsson, Niklas, Louvaris, Zafeiris, Palmerini, Luca, Polkey, Michael I., Puhan, Milo A., Rabinovich, Roberto A., Rodríguez Chiaradia, Diego A., Rodriguez-Roisin, Robert, Toran-Montserrat, Pere, and Vogiatzis, Ioannis
- Published
- 2024
- Full Text
- View/download PDF
15. Is blinding in studies of manual soft tissue mobilisation of the back possible? A feasibility randomised controlled trial with Swiss graduate students.
- Author
-
Muñoz Laguna, Javier, Nyantakyi, Emanuela, Bhattacharyya, Urmila, Blum, Kathrin, Delucchi, Matteo, Klingebiel, Felix Karl-Ludwig, Labarile, Marco, Roggo, Andrea, Weber, Manuel, Radtke, Thomas, Puhan, Milo A, and Hincapié, Cesar A
- Subjects
TREATMENT of backaches ,CONFIDENCE intervals ,RANGE of motion of joints ,BREATHING exercises ,HEALTH outcome assessment ,TREATMENT effectiveness ,RANDOMIZED controlled trials ,MANIPULATION therapy ,DESCRIPTIVE statistics ,BLIND experiment ,STATISTICAL sampling ,THEMATIC analysis - Abstract
Study design: Single-centre, two-parallel group, methodological randomised controlled trial to assess blinding feasibility. Background: Trials of manual therapy interventions of the back face methodological challenges regarding blinding feasibility and success. We assessed the feasibility of blinding an active manual soft tissue mobilisation and control intervention of the back. We also assessed whether blinding is feasible among outcome assessors and explored factors influencing perceptions about intervention assignment. Methods: On 7–8 November 2022, 24 participants were randomly allocated (1:1 ratio) to active or control manual interventions of the back. The active group (n = 11) received soft tissue mobilisation of the lumbar spine. The control group (n = 13) received light touch over the thoracic region with deep breathing exercises. The primary outcome was blinding of participants immediately after a one-time intervention session, as measured by the Bang blinding index (Bang BI). Bang BI ranges from –1 (complete opposite perceptions of intervention received) to 1 (complete correct perceptions), with 0 indicating 'random guessing'—balanced 'active' and 'control' perceptions within an intervention arm. Secondary outcomes included blinding of outcome assessors and factors influencing perceptions about intervention assignment among both participants and outcome assessors, explored via thematic analysis. Results: 24 participants were analysed following an intention-to-treat approach. 55% of participants in the active manual soft tissue mobilisation group correctly perceived their group assignment beyond chance immediately after intervention (Bang BI: 0.55 [95% confidence interval (CI), 0.25 to 0.84]), and 8% did so in the control group (0.08 [95% CI, −0.37 to 0.53]). Bang BIs in outcome assessors were 0.09 (−0.12 to 0.30) and −0.10 (−0.29 to 0.08) for active and control participants, respectively. Participants and outcome assessors reported varying factors related to their perceptions about intervention assignment. Conclusions: Blinding of participants allocated to an active soft tissue mobilisation of the back was not feasible in this methodological trial, whereas blinding of participants allocated to the control intervention and outcome assessors was adequate. Findings are limited due to imprecision and suboptimal generalisability to clinical settings. Careful thinking and consideration of blinding in manual therapy trials is warranted and needed. Trial registration: ClinicalTrials.gov: NCT05822947 (retrospectively registered) [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
16. Absence of Type I Interferon Autoantibodies or Significant Interferon Signature Alterations in Adults With Post–COVID-19 Syndrome.
- Author
-
Achleitner, Martin, Mair, Nina K, Dänhardt, Juliane, Kardashi, Romina, Puhan, Milo A, Abela, Irene A, Toepfner, Nicole, With, Katja de, Kanczkowski, Waldemar, Jarzebska, Natalia, Rodionov, Roman N, Wolf, Christine, Lee-Kirsch, Min Ae, Steenblock, Charlotte, Hale, Benjamin G, and Bornstein, Stefan R
- Subjects
TYPE I interferons ,AUTOANTIBODIES ,COVID-19 pandemic ,INTERFERONS ,FATIGUE (Physiology) ,POSTPOLIOMYELITIS syndrome - Abstract
Genetic defects in the interferon (IFN) system or neutralizing autoantibodies against type I IFNs contribute to severe COVID-19. Such autoantibodies were proposed to affect post–COVID-19 syndrome (PCS), possibly causing persistent fatigue for >12 weeks after confirmed SARS-CoV-2 infection. In the current study, we investigated 128 patients with PCS, 21 survivors of severe COVID-19, and 38 individuals who were asymptomatic. We checked for autoantibodies against IFN-α, IFN-β, and IFN-ω. Few patients with PCS had autoantibodies against IFNs but with no neutralizing activity, indicating a limited role of type I IFNs in PCS pathogenesis. In a subset consisting of 28 patients with PCS, we evaluated IFN-stimulated gene activity and showed that it did not correlate with fatigue. In conclusion, impairment of the type I IFN system is unlikely responsible for adult PCS. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
17. Development of hybrid immunity during a period of high incidence of Omicron infections.
- Author
-
Frei, Anja, Kaufmann, Marco, Amati, Rebecca, Dettwiler, Audrey Butty, Wyl, Viktor von, Annoni, Anna Maria, Vincentini, Julia, Pellaton, Céline, Pantaleo, Giuseppe, Fehr, Jan S, D'Acremont, Valérie, Bochud, Murielle, Albanese, Emiliano, Puhan, Milo A, and Group, Corona Immunitas Research
- Subjects
SARS-CoV-2 Omicron variant ,IMMUNOGLOBULINS ,BOOSTER vaccines ,SARS-CoV-2 ,IMMUNITY ,ANTIBODY titer - Abstract
Background Seroprevalence and the proportion of people with neutralizing activity (functional immunity) against SARS-CoV-2 variants were high in early 2022. In this prospective, population- based, multi-region cohort study, we assessed the development of functional and hybrid immunity (induced by vaccination and infection) in the general population during this period of high incidence of infections with Omicron variants. Methods We randomly selected and assessed individuals aged ≥16 years from the general population in southern (n = 739) and north-eastern (n = 964) Switzerland in March 2022. We assessed them again in June/July 2022, supplemented with a random sample from western (n = 850) Switzerland. We measured SARS-CoV-2 specific IgG antibodies and SARS-CoV-2 neutralizing antibodies against three variants (ancestral strain, Delta, Omicron). Results Seroprevalence remained stable from March 2022 (97.6%, n = 1894) to June/July 2022 (98.4%, n = 2553). In June/July, the percentage of individuals with neutralizing capacity against ancestral strain was 94.2%, against Delta 90.8% and against Omicron 84.9%, and 50.6% developed hybrid immunity. Individuals with hybrid immunity had highest median levels of anti-spike IgG antibodies titres [4518 World Health Organization units per millilitre (WHO U/mL)] compared with those with only vaccine- (4304 WHO U/mL) or infection- (269 WHO U/mL) induced immunity, and highest neutralization capacity against ancestral strain (hybrid: 99.8%, vaccinated: 98%, infected: 47.5%), Delta (hybrid: 99%, vaccinated: 92.2%, infected: 38.7%) and Omicron (hybrid: 96.4%, vaccinated: 79.5%, infected: 47.5%). Conclusions This first study on functional and hybrid immunity in the Swiss general population after Omicron waves showed that SARS-CoV-2 has become endemic. The high levels of antibodies and neutralization support the emerging recommendations of some countries where booster vaccinations are still strongly recommended for vulnerable persons but less so for the general population. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
18. The Ready-To-Go Questionnaire predicts health outcomes during travel: a smartphone application-based analysis.
- Author
-
Maier, Julian D, Anagnostopoulos, Alexia, Gazzotti, Anna, Bühler, Silja, Baroutsou, Vasiliki, Hatz, Christoph, Puhan, Milo A, Fehr, Jan, and Farnham, Andrea
- Subjects
HEALTH risk assessment ,TRAVEL websites ,TRAVEL hygiene ,DISEASE risk factors ,HEALTH behavior - Abstract
Background The Ready-To-Go (R2G) Questionnaire is a tool for rapid assessment of health risks for travel consultation. This study aims to assess the utility of the R2G Questionnaire in identifying high-risk travellers and predicting health events and behaviour during travel in the TOURIST2 prospective cohort. Methods TOURIST2 data were used to calculate the R2G medical and travel risk scores and categorize each participant based on their risk. The TOURIST2 study enrolled 1000 participants from Switzerland's largest travel clinics between 2017 and 2019. Participants completed daily smartphone application surveys before, during and after travel on health events and behaviours. We used regression models to analyse incidence of overall health events and of similar health events grouped into health domains (e.g. respiratory, gastrointestinal, accident/injury). Incidence rate ratios (IRR) are displayed with 95% confidence intervals (95% CI). Results R2G high-risk travellers experienced significantly greater incidence of health events compared to lower-risk travellers (IRR = 1.27, 95% CI: 1.22–1.33). Both the medical and travel scores showed significant positive associations with incidence of health events during travel (IRR = 1.11, 95% CI: 1.07–1.16; IRR = 1.07, 95% CI: 1.03–1.12, respectively), with significant increases in all health domains except skin disorders. Medical and travel risk scores were associated with different patterns in behaviour. Travellers with chronic health conditions accessed medical care during travel more often (IRR = 1.16, 95% CI: 1.03–1.31), had greater difficulty in carrying out planned activities (IRR = –0.04, 95% CI: –0.05, –0.02), and rated their travel experience lower (IRR = –0.04, 95% CI: –0.06, –0.02). Travellers with increased travel-related risks due to planned travel itinerary had more frequent animal contact (IRR = 1.09, 95% CI: 1.01–1.18) and accidents/injuries (IRR = 1.28, 95% CI: 1.15–1.44). Conclusions The R2G Questionnaire is a promising risk assessment tool that offers a timesaving and reliable means to identify high-risk travellers. Incorporated into travel medicine websites, it could serve as a pre-consultation triage to help travellers self-identify their risk level, direct them to the appropriate medical provider(s), and help practitioners in giving more tailored advice. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
19. Associations of multilingualism and language proficiency with cognitive functioning: epidemiological evidence from the SwissDEM study in community dwelling older adults and long-term care residents.
- Author
-
Pacifico, Deborah, Sabatini, Serena, Fiordelli, Maddalena, Annoni, Anna Maria, Frei, Anja, Puhan, Milo, Graf, Gwendolyn, and Albanese, Emiliano
- Subjects
LANGUAGE ability ,COGNITIVE ability ,OLDER people ,LONG-term health care ,VERBAL behavior testing ,SHORT-term memory - Abstract
Background: We explored whether number of languages spoken and language proficiency are associated with cognitive performance among older adults living in the community and in long-term care (LTC) in Switzerland. Methods: Among study participants, 664 lived in the community in the Canton of Zurich (Mean age = 72.97 years; SD = 6.08), 386 lived in the community in Ticino (Mean age = 76.24 years; SD = 6.66), and 176 resided in LTC in Ticino (Mean age = 87.61 years; SD = 6.45). We recorded sociodemographic variables, number of languages spoken, language proficiency, and assessed overall cognitive performance, immediate and delayed memory, and verbal fluency with standardized tests. We used adjusted regression models. Results: A higher number of spoken languages was positively associated with overall cognitive performance, verbal fluency and immediate and delayed memory performance in community-dwelling older adults in the Cantons of Ticino and Zurich, (all p values ≤ 0.012;), but not in in older adults living in LTC homes (all p values ≥ 0.35). Higher language proficiency was associated with better memory performance among individuals living in the community in Ticino (p value = 0.003), and to better performance in verbal fluency and memory tasks in Zurich (p values ≤ 0.002). Among LTC residents, proficiency levels were not associated with cognitive performance. Conclusions: Multilingualism and greater language proficiency were associated with better cognitive functioning in community-dwelling but not in institutionalized older adults. Multilingualism may contribute to cognitive reserve, as well as protect and delay cognitive decline in late life. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
20. Needs assessment in community-dwelling older adults toward digital interventions to promote physical activity: Cross-sectional survey study.
- Author
-
Weber, Manuel, Schmitt, Kai-Uwe, Frei, Anja, Puhan, Milo A, and Raab, Anja M
- Published
- 2023
- Full Text
- View/download PDF
21. Blending citizen science with natural language processing and machine learning: Understanding the experience of living with multiple sclerosis.
- Author
-
Haag, Christina, Steinemann, Nina, Chiavi, Deborah, Kamm, Christian P., Sieber, Chloé, Manjaly, Zina-Mary, Horváth, Gábor, Ajdacic-Gross, Vladeta, Puhan, Milo Alan, and von Wyl, Viktor
- Published
- 2023
- Full Text
- View/download PDF
22. Increased red blood cell deformation in children and adolescents after SARS-CoV-2 infection.
- Author
-
Eder, Julian, Schumm, Leonie, Armann, Jakob P., Puhan, Milo A., Beuschlein, Felix, Kirschbaum, Clemens, Berner, Reinhard, and Toepfner, Nicole
- Subjects
ERYTHROCYTES ,HEMORHEOLOGY ,SARS-CoV-2 ,COVID-19 ,TEENAGERS ,OLDER patients ,INFECTION - Abstract
Severe coronavirus disease 2019 (COVID-19) is associated with hyperinflammation, hypercoagulability and hypoxia. Red blood cells (RBCs) play a key role in microcirculation and hypoxemia and are therefore of special interest in COVID-19 pathophysiology. While this novel disease has claimed the lives of many older patients, it often goes unnoticed or with mild symptoms in children. This study aimed to investigate morphological and mechanical characteristics of RBCs after SARS-CoV-2 infection in children and adolescents by real-time deformability-cytometry (RT-DC), to investigate the relationship between alterations of RBCs and clinical course of COVID-19. Full blood of 121 students from secondary schools in Saxony, Germany, was analyzed. SARS-CoV-2-serostatus was acquired at the same time. Median RBC deformation was significantly increased in SARS-CoV-2-seropositive compared to seronegative children and adolescents, but no difference could be detected when the infection dated back more than 6 months. Median RBC area was the same in seropositive and seronegative adolescents. Our findings of increased median RBC deformation in SARS-CoV-2 seropositive children and adolescents until 6 months post COVID-19 could potentially serve as a progression parameter in the clinical course of the disease with an increased RBC deformation pointing towards a mild course of COVID-19. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
23. Recovery and symptom trajectories up to two years after SARS-CoV-2 infection: population based, longitudinal cohort study.
- Author
-
Ballouz, Tala, Menges, Dominik, Anagnostopoulos, Alexia, Domenghino, Anja, Aschmann, Hélène E., Frei, Anja, Fehr, Jan S., and Puhan, Milo A.
- Subjects
MEMORY ,COVID-19 ,CONFIDENCE intervals ,CONVALESCENCE ,TIME ,SELF-evaluation ,POST-acute COVID-19 syndrome ,HEALTH status indicators ,DYSPNEA ,SMELL ,ATTENTION ,DESCRIPTIVE statistics ,RESEARCH funding ,TASTE ,FATIGUE (Physiology) ,LONGITUDINAL method - Published
- 2023
- Full Text
- View/download PDF
24. Adverse effects, perceptions and attitudes related to BNT162b2, mRNA-1273 or JNJ-78436735 SARS-CoV-2 vaccines: Population-based cohort.
- Author
-
Bürzle, Oliver, Menges, Dominik, Maier, Julian D., Schams, Daniel, Puhan, Milo A., Fehr, Jan, Ballouz, Tala, and Frei, Anja
- Subjects
COVID-19 vaccines ,VACCINE safety ,TRUST ,VACCINATION ,ATTITUDE (Psychology) - Abstract
Long-term control of SARS-CoV-2 requires effective vaccination strategies. This has been challenged by public mistrust and the spread of misinformation regarding vaccine safety. Better understanding and communication of the longer-term and comparative experiences of individuals in the general population following vaccination are required. In this population-based longitudinal study, we included 575 adults, randomly selected from all individuals presenting to a Swiss reference vaccination center, for receipt of BNT162b2, mRNA1273, or JNJ-78436735. We assessed the prevalence, onset, duration, and severity of self-reported adverse effects over 12 weeks following vaccination. We additionally evaluated participants' perceptions of vaccines, trust in public health authorities and pharmaceutical companies, and compliance with public health measures. Most participants reported at least one adverse effect within 12 weeks following vaccination. Adverse effects were mostly mild or moderate, resolved within three days, and rarely resulted in anaphylaxis or hospitalizations. Female sex, younger age, higher education, and receipt of mRNA-1273 were associated with reporting adverse effects. Compared to JNJ-78436735 recipients, a higher proportion of mRNA vaccine recipients agreed that vaccination is important, and trusted public health authorities. Our findings provide real-world estimates of the prevalence of adverse effects following SARS-CoV-2 vaccination and highlight the importance of transparent communication to ensure the success of current or future vaccination campaigns. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
25. The Swiss chiropractic practice-based research network: a population-based cross-sectional study to inform future musculoskeletal research.
- Author
-
Lalji, Rahim, Hofstetter, Léonie, Kongsted, Alice, von Wyl, Viktor, Puhan, Milo A., and Hincapié, Cesar A.
- Subjects
CHIROPRACTIC ,MEDICAL quality control ,CROSS-sectional method ,CHIROPRACTORS - Abstract
The Swiss chiropractic practice-based research network (PBRN) is a nationwide project developed in collaboration with patients, clinicians, and academic stakeholders to advance musculoskeletal epidemiologic research. The aim of this study was to describe the clinician population recruited and representativeness of this PBRN to inform future collaboration. A population-based cross-sectional study was performed. PBRN clinician characteristics were described and factors related to motivation (operationalised as VAS score ≥ 70) to participate in a subsequent patient cohort pilot study were assessed. Among 326 eligible chiropractors, 152 enrolled in the PBRN (47% participation). The PBRN was representative of the larger Swiss chiropractic population with regards to age, language, and geographic distribution. Of those enrolled, 39% were motivated to participate in a nested patient cohort pilot study. Motivation was associated with age 40 years or older versus 39 years or younger (OR 2.3, 95% CI 1.0–5.2), and with a moderate clinic size (OR 2.4, 95% CI 1.1–5.7) or large clinic size (OR 2.8, 95% CI 1.0–7.8) versus solo practice. The Swiss chiropractic PBRN has enrolled almost half of all Swiss chiropractors and has potential to facilitate collaborative practice-based research to improve musculoskeletal health care quality. Trial registration: Swiss chiropractic PBRN (ClinicalTrials.gov identifier: NCT05046249); Swiss chiropractic cohort (Swiss ChiCo) pilot study (ClinicalTrials.gov identifier: NCT05116020). [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
26. Joys or Sorrows of Parenting During the COVID-19 Lockdown: A Scoping Review.
- Author
-
Fadda, Marta, Melotto, Matilde, Caiata-Zufferey, Maria, Puhan, Milo Alan, Frei, Anja, Albanese, Emiliano, and Camerini, Anne-Linda
- Subjects
STAY-at-home orders ,HEALTH policy ,COVID-19 ,PARENTING ,GRIEF - Abstract
Objectives: The aim of this scoping review was to map out the existing evidence of the impact of the COVID-19 lockdown on parents of children and adolescents. We sought to: 1) identify parenting domains that were particularly affected by lockdown measures, 2) describe the challenges and opportunities of lockdown measures in these domains, and 3) define protective and exacerbating factors modulating the effect of lockdown measures on parents. Methods: We identified five main domains investigated in the context of parenting during the early COVID-19 lockdown derived from 84 studies: health and wellbeing, parental role, couple functioning, family and social relationships, and paid and unpaid work. For each domain, we listed challenges and opportunities, as well as discriminant factors. Results: The lockdown impacted all five different but interconnected domains, introduced new roles in parents' lives, and particularly affected women and vulnerable populations. Conclusion: This scoping review highlights the importance of approaching public health policymaking from a social justice perspective. Such an approach argues for social and public health policies to promote health accounting for its social, economic, political, and commercial determinants. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
27. Association between serologically confirmed COVID-19 infection and cognitive functioning in community dwelling older adults.
- Author
-
Sabatini, Serena, Pacifico, Deborah, Frei, Anja, Graf, Gwendolyn, Puhan, Milo A., and Albanese, Emiliano
- Subjects
COVID-19 ,COGNITIVE ability ,OLDER people ,COMMUNITIES ,VACCINATION status - Abstract
Introduction: COVID-19 infection can impact the central nervous system, and is often associated with cognitive decline. However, there are no studies linking serologically confirmed COVID-19 infection with objectively assessed cognitive functioning. We explored whether presence of SARS-CoV-2 antibodies account for variability in participants’ scores on a neuropsychological assessment. Methods: In this cross-sectional study participants were 657 (mean age = 72.97; SD = 6.07 years; women = 47.7%) individuals randomly selected from the general population of the canton of Zurich and included in the Corona Immunitas study. We conducted serological tests between October 2020 and May 2021 to detect and quantify SARS-CoV-2 antibodies in peripheral venous blood samples. We assessed cognitive function, vaccination status (vaccinated; not vaccinated), number of health conditions, and demographic variables between January and August 2021. We studied the association between seropositivity and global cognitive function and five cognitive domains (language expression, language comprehension, temporal orientation, spatial orientation, and memory) with linear regression models. Based on SARS-CoV-2 antibodies and vaccination status, we stratified participants into three groups: No SARS-CoV-2 antibodies (N = 402); SARS-CoV-2 antibodies due to vaccination (N = 218); history of SARS-CoV-2 infection and no vaccination (N = 37). Results: In the regression model adjusted for age, sex, educational level, and number of health conditions, compared to those without SARS-CoV-2 antibodies, those with SARS-CoV-2 antibodies due to vaccination had better global cognitive functioning (Standardized beta = 0.10; 95% CI = 0.02; 0.17), and those with SARS-CoV-2 antibodies due to infection had poorer cognitive functioning (Standardized beta = −0.10; 95% CI = −0.18; −0.03). Regarding cognitive domains, compared to those without SARSCoV-2 antibodies, those with SARS-CoV-2 antibodies due to infection scored more poorly on language comprehension and temporal orientation, and those with SARSCoV-2 antibodies due to vaccination scored better on memory. Discussion: By linking serologically confirmed presence of SARS-CoV-2 antibodies to poorer global cognitive functioning in community dwelling older adults we strengthen existing evidence in support of cognitive decline related to COVID-19. Given the large number of infected older adults, and the endurance of the pandemic, our results highlight the need to address COVID-19 related cognitive decline in the clinical and public health areas of prevention, diagnosis, and treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
28. Post COVID-19 condition after Wildtype, Delta, and Omicron SARS-CoV-2 infection and prior vaccination: Pooled analysis of two population-based cohorts.
- Author
-
Ballouz, Tala, Menges, Dominik, Kaufmann, Marco, Amati, Rebecca, Frei, Anja, von Wyl, Viktor, Fehr, Jan S., Albanese, Emiliano, and Puhan, Milo A.
- Subjects
SARS-CoV-2 Omicron variant ,SARS-CoV-2 ,COVID-19 ,VACCINATION ,CLUSTER analysis (Statistics) ,HIERARCHICAL clustering (Cluster analysis) ,LOGISTIC regression analysis - Abstract
Background: Post COVID-19 condition (PCC) is an important complication of SARS-CoV-2 infection, affecting millions worldwide. This study aimed to evaluate the prevalence and severity of post COVID-19 condition (PCC) with novel SARS-CoV-2 variants and after prior vaccination. Methods: We used pooled data from 1350 SARS-CoV-2-infected individuals from two representative population-based cohorts in Switzerland, diagnosed between Aug 5, 2020, and Feb 25, 2022. We descriptively analysed the prevalence and severity of PCC, defined as the presence and frequency of PCC-related symptoms six months after infection, among vaccinated and non-vaccinated individuals infected with Wildtype, Delta, and Omicron SARS-CoV-2. We used multivariable logistic regression models to assess the association and estimate the risk reduction of PCC after infection with newer variants and prior vaccination. We further assessed associations with the severity of PCC using multinomial logistic regression. To identify groups of individuals with similar symptom patterns and evaluate differences in the presentation of PCC across variants, we performed exploratory hierarchical cluster analyses. Results: We found strong evidence that vaccinated individuals infected with Omicron had reduced odds of developing PCC compared to non-vaccinated Wildtype-infected individuals (odds ratio 0.42, 95% confidence interval 0.24–0.68). The odds among non-vaccinated individuals were similar after infection with Delta or Omicron compared to Wildtype SARS-CoV-2. We found no differences in PCC prevalence with respect to the number of received vaccine doses or timing of last vaccination. The prevalence of PCC-related symptoms among vaccinated, Omicron-infected individuals was lower across severity levels. In cluster analyses, we identified four clusters of diverse systemic, neurocognitive, cardiorespiratory, and musculoskeletal symptoms, with similar patterns across variants. Conclusion: The risk of PCC appears to be lowered with infection by the Omicron variant and after prior vaccination. This evidence is crucial to guide future public health measures and vaccination strategies. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
29. Trajectories of Seroprevalence and Neutralizing Activity of Antibodies against SARS-CoV-2 in Southern Switzerland between July 2020 and July 2021: An Ongoing, Prospective Population-Based Cohort Study.
- Author
-
Amati, Rebecca, Piumatti, Giovanni, Franscella, Giovanni, Buttaroni, Peter, Camerini, Anne-Linda, Corna, Laurie, Levati, Sara, Fadda, Marta, Fiordelli, Maddalena, Annoni, Anna Maria, Bezani, Kleona, Amendola, Antonio, Fragoso Corti, Cristina, Sabatini, Serena, Kaufmann, Marco, Frei, Anja, Puhan, Milo Alan, Crivelli, Luca, and Albanese, Emiliano
- Published
- 2023
- Full Text
- View/download PDF
30. Nationwide indoor smoking ban and impact on smoking behaviour and lung function: a two-population natural experiment.
- Author
-
Strassmann, Alexandra, Çolak, Yunus, Serra-Burriel, Miquel, Nordestgaard, Børge G., Turk, Alexander, Afzal, Shoaib, and Puhan, Milo A.
- Subjects
SMOKING bans ,NICOTINE replacement therapy ,LUNGS ,TOBACCO smoke pollution - Published
- 2023
- Full Text
- View/download PDF
31. Beyond high hopes: A scoping review of the 2019–2021 scientific discourse on machine learning in medical imaging.
- Author
-
Nittas, Vasileios, Daniore, Paola, Landers, Constantin, Gille, Felix, Amann, Julia, Hubbs, Shannon, Puhan, Milo Alan, Vayena, Effy, and Blasimme, Alessandro
- Published
- 2023
- Full Text
- View/download PDF
32. Listening to the patients' voice: a conceptual framework of the walking experience.
- Author
-
Delgado-Ortiz, Laura, Polhemus, Ashley, Keogh, Alison, Sutton, Norman, Remmele, Werner, Hansen, Clint, Kluge, Felix, Sharrack, Basil, Becker, Clemens, Troosters, Thierry, Maetzler, Walter, Rochester, Lynn, Frei, Anja, Puhan, Milo A, and Garcia-Aymerich, Judith
- Subjects
MULTIPLE sclerosis ,FRAIL elderly ,HUMAN voice ,HIP fractures ,SARCOPENIA ,EXPERIENCE ,CONCEPTUAL structures ,QUALITATIVE research ,WALKING ,PARKINSON'S disease ,OBSTRUCTIVE lung diseases ,AGING ,LISTENING ,HEART failure - Abstract
Background walking is crucial for an active and healthy ageing, but the perspectives of individuals living with walking impairment are still poorly understood. Objectives to identify and synthesise evidence describing walking as experienced by adults living with mobility-impairing health conditions and to propose an empirical conceptual framework of walking experience. Methods we performed a systematic review and meta-ethnography of qualitative evidence, searching seven electronic databases for records that explored personal experiences of walking in individuals living with conditions of diverse aetiology. Conditions included Parkinson's disease, multiple sclerosis, chronic obstructive pulmonary disease, hip fracture, heart failure, frailty and sarcopenia. Data were extracted, critically appraised using the NICE quality checklist and synthesised using standardised best practices. Results from 2,552 unique records, 117 were eligible. Walking experience was similar across conditions and described by seven themes: (i) becoming aware of the personal walking experience, (ii) the walking experience as a link between individuals' activities and sense of self, (iii) the physical walking experience, (iv) the mental and emotional walking experience, (v) the social walking experience, (vi) the context of the walking experience and (vii) behavioural and attitudinal adaptations resulting from the walking experience. We propose a novel conceptual framework that visually represents the walking experience, informed by the interplay between these themes. Conclusion a multi-faceted and dynamic experience of walking was common across health conditions. Our conceptual framework of the walking experience provides a novel theoretical structure for patient-centred clinical practice, research and public health. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
33. Causal Mediation Analysis with Multiple Time-varying Mediators.
- Author
-
Tai, An-Shun, Lin, Sheng-Hsuan, Chu, Yu-Cheng, Yu, Tsung, Puhan, Milo A., and VanderWeele, Tyler
- Published
- 2023
- Full Text
- View/download PDF
34. Needs assessment in community-dwelling older adults toward digital interventions to promote physical activity: Cross-sectional survey study.
- Author
-
Weber, Manuel, Schmitt, Kai-Uwe, Frei, Anja, Puhan, Milo A., and Raab, Anja M.
- Published
- 2023
- Full Text
- View/download PDF
35. Is Statistical Significance Alone Obsolete? Let’s Turn to Meaningful Interpretation of Scientific and Real-world Evidence on Surgical Care.
- Author
-
Puhan, Milo A. and Clavien, Pierre-Alain
- Published
- 2024
- Full Text
- View/download PDF
36. Swiss Cohort & Biobank – The White Paper.
- Author
-
Probst-Hensch, Nicole, Bochud, Murielle, Chiolero, Arnaud, Crivelli, Luca, Dratva, Julia, Flahault, Antoine, Frey, Daniel, Kuenzli, Nino, Puhan, Milo, Suggs, L. Suzanne, and Wirth, Corina
- Subjects
MEDICAL care ,PUBLIC health - Published
- 2022
- Full Text
- View/download PDF
37. Effectiveness of a Long-term Home-Based Exercise Training Program in Patients With COPD After Pulmonary Rehabilitation: A Multicenter Randomized Controlled Trial.
- Author
-
Frei, Anja, Radtke, Thomas, Dalla Lana, Kaba, Brun, Patrick, Sigrist, Thomas, Spielmanns, Marc, Beyer, Swantje, Riegler, Thomas F., Büsching, Gilbert, Spielmanns, Sabine, Kunz, Ramona, Cerini, Tamara, Braun, Julia, Tomonaga, Yuki, Serra-Burriel, Miquel, Polhemus, Ashley, and Puhan, Milo A.
- Subjects
EXERCISE therapy ,CHRONIC obstructive pulmonary disease ,QUALITY of life ,STRENGTH training ,EXERCISE tests ,AEROBIC capacity ,BODY-weight-supported treadmill training - Abstract
Background: Most patients with COPD do not maintain exercise training after pulmonary rehabilitation (PR).Research Question: Does a 12-month home-based, minimal-equipment strength training program after PR have an effect on dyspnea, exercise capacity, and patient-reported outcomes in patients with COPD?Study Design and Methods: In a parallel-arm multicenter study across four Swiss PR clinics, patients with COPD were allocated randomly (1:1 ratio) into an intervention group (IG; home-based strength training program) or control group (CG; usual care). The primary outcome was change in Chronic Respiratory Questionnaire (CRQ) dyspnea scale score from baseline to 12 months. Secondary outcomes were change in exercise capacity (1-min sit-to-stand-test [1MSTST], 6-min walk test [6MWT]), health-related quality of life, exacerbations, and symptoms. We assessed the IG's experience by interviews at study end. Main analyses were based on the intention-to-treat approach, and adjusted linear regression models were used.Results: One hundred twenty-three patients with COPD (IG, n = 61; CG, n = 62) were randomized, 61 of whom were women and whose mean ± SD age was 66.8 ± 8.1 years and mean ± SD FEV1 was 39.3 ± 15.3% predicted. One hundred four participants completed 12 months of follow-up (IG, n= 53; CG, n= 51). Of the 53 IG participants, 37 participants (70%) conducted the training until study end. We found no difference in change in CRQ dyspnea scale score over 12 months (adjusted mean difference, 0.28; 95% CI, -0.23 to 0.80; P = .27). We found moderate evidence for a difference in 1MSTST repetitions favoring the IG (adjusted mean difference, 2.6; 95% CI, 0.22-5.03; P = .033), but no evidence for an effect in other outcomes. Seventy-nine percent of the IG reported positive effects that they attributed to the training.Interpretation: The home exercise program had no effect on dyspnea, but improved 1MSTST performance and patient-perceived fitness. The supported program was well accepted by patients with COPD and may facilitate continued exercise training at home.Trial Registry: ClinicalTrials.gov; No.: NCT03461887; URL: www.Clinicaltrials: gov. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
38. The Real-World Experiences of Persons With Multiple Sclerosis During the First COVID-19 Lockdown: Application of Natural Language Processing.
- Author
-
Chiavi, Deborah, Haag, Christina, Chan, Andrew, Kamm, Christian Philipp, Sieber, Chloé, Stanikić, Mina, Rodgers, Stephanie, Pot, Caroline, Kesselring, Jürg, Salmen, Anke, Rapold, Irene, Calabrese, Pasquale, Manjaly, Zina-Mary, Gobbi, Claudio, Zecca, Chiara, Walther, Sebastian, Stegmayer, Katharina, Hoepner, Robert, Puhan, Milo, and von Wyl, Viktor
- Published
- 2022
- Full Text
- View/download PDF
39. Post COVID and Apheresis – Where are we Standing?
- Author
-
Steenblock, Charlotte, Walther, Romy, Tselmin, Sergey, Jarzebska, Natalia, Voit-Bak, Karin, Toepfner, Nicole, Siepmann, Timo, Passauer, Jens, Hugo, Christian, Wintermann, Gloria, Julius, Ulrich, Barbir, Mahmoud, Khan, Tina Z., Puhan, Milo A., Straube, Richard, Hohenstein, Bernd, Bornstein, Stefan R., and Rodionov, Roman N.
- Subjects
COVID-19 ,HEMAPHERESIS ,POST-acute COVID-19 syndrome ,HEALTH facilities ,RANDOMIZED controlled trials ,SYMPTOMS - Abstract
A continual increase in cases of Long/Post COVID constitutes a medical and socioeconomic challenge to health systems around the globe. While the true extent of this problem cannot yet be fully evaluated, recent data suggest that up to 20% of people with confirmed SARS-CoV-2 suffer from clinically relevant symptoms of Long/Post COVID several weeks to months after the acute phase. The clinical presentation is highly variable with the main symptoms being chronic fatigue, dyspnea, and cognitive symptoms. Extracorporeal apheresis has been suggested to alleviate symptoms of Post/COVID. Thus, numerous patients are currently treated with apheresis. However, at present there is no data from randomized controlled trials available to confirm the efficacy. Therefore, physicians rely on the experience of practitioners and centers performing this treatment. Here, we summarize clinical experience on extracorporeal apheresis in patients with Post/COVID from centers across Germany. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
40. Survival modelling and cost-effectiveness analysis of treatments for newly diagnosed metastatic hormone-sensitive prostate cancer.
- Author
-
Barbier, Michaela C., Tomonaga, Yuki, Menges, Dominik, Yebyo, Henock G., Haile, Sarah R., Puhan, Milo A., and Schwenkglenks, Matthias
- Subjects
PROSTATE cancer ,PROGRESSION-free survival ,COST effectiveness ,ANDROGEN deprivation therapy ,PURCHASING power parity ,OVERALL survival - Abstract
Background: In metastatic hormone-sensitive prostate cancer (mHSPC) treatment, survival benefits have been shown by adding docetaxel or recent androgen receptor axis-targeted therapies (ARATs) abiraterone, apalutamide, or enzalutamide to androgen deprivation therapy (ADT). However, the optimal treatment strategy in terms of costs and effects is unclear, not least due to high ARAT costs. Methods: To assess treatment cost-effectiveness, we developed a Markov cohort model with health states of progression-free disease, progressive disease and death for men with newly diagnosed mHSPC, with a 30-year time horizon. Survival data, adverse events and utilities were informed by randomized controlled trial results, our meta-analysis of re-created individual patient survival data, and publicly available sources of unit costs. We applied a Swiss healthcare payer perspective and discounted costs and effects by 3%. Results: We found a significant overall survival benefit for ADT+abiraterone versus ADT+docetaxel. The corresponding incremental cost-effectiveness ratio (ICER) was predicted to be EUR 39,814 per quality-adjusted life-year (QALY) gained. ADT+apalutamide and ADT+enzalutamide incurred higher costs and lower QALYs compared to ADT+abiraterone. For all ARATs, drug costs constituted the most substantial cost component. Results were stable except for a large univariable reduction in the pre-progression utility under ADT+abiraterone and very large variations in drug prices. Conclusions: Our model projected ADT+abiraterone to be cost-effective compared to ADT+docetaxel at a willingness-to-pay threshold of EUR 70,400/QALY (CHF 100,000 applying purchasing power parities). Given lower estimated QALYs for ADT+apalutamide and ADT+enzalutamide compared to ADT+abiraterone, the former only became cost-effective (the preferred) treatment option(s) at substantial 75–80% (80–90%) price reductions. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
41. Individual participant data meta-analysis with mixed-effects transformation models.
- Author
-
Tamási, Bálint, Crowther, Michael, Puhan, Milo Alan, Steyerberg, Ewout W, and Hothorn, Torsten
- Subjects
COMPUTER simulation ,RESEARCH ,META-analysis ,RESEARCH methodology ,REGRESSION analysis ,EVALUATION research ,COMPARATIVE studies ,QUESTIONNAIRES ,RESEARCH funding ,STATISTICAL models - Abstract
One-stage meta-analysis of individual participant data (IPD) poses several statistical and computational challenges. For time-to-event outcomes, the approach requires the estimation of complicated nonlinear mixed-effects models that are flexible enough to realistically capture the most important characteristics of the IPD. We present a model class that incorporates general normally distributed random effects into linear transformation models. We discuss extensions to model between-study heterogeneity in baseline risks and covariate effects and also relax the assumption of proportional hazards. Within the proposed framework, data with arbitrary random censoring patterns can be handled. The accompanying $\textsf{R}$ package tramME utilizes the Laplace approximation and automatic differentiation to perform efficient maximum likelihood estimation and inference in mixed-effects transformation models. We compare several variants of our model to predict the survival of patients with chronic obstructive pulmonary disease using a large data set of prognostic studies. Finally, a simulation study is presented that verifies the correctness of the implementation and highlights its efficiency compared to an alternative approach. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
42. Performance Score (T2D)—A New Perspective in the Assessment of Six-Minute Walking Tests in Pulmonary Rehabilitation.
- Author
-
Wagner, Barbara, Zdravkovic, Andrej, Pirchl, Michael, Puhan, Milo A., Zwick, Ralf Harun, Grote, Vincent, Crevenna, Richard, and Fischer, Michael J.
- Subjects
REHABILITATION ,FUNCTIONAL status ,CHRONIC obstructive pulmonary disease ,AEROBIC capacity - Abstract
Because absolute changes in outcomes are difficult to interpret and the minimal clinically important difference (MCID) is not suitable to address this challenge, a novel method of classifying outcomes by relating changes to baseline values is warranted. We used the "performance score" (T2D), which reflects individual performance, enabling us to consider the functional status at the beginning of rehabilitation without dealing with the problems of mathematical coupling or regression effects, as encountered in ANCOVA. To illustrate the T2D, we retrospectively analyzed changes in the six-minute walking test (6MWT) in COPD patients undergoing outpatient pulmonary rehabilitation and compared the results with absolute differences related to a predetermined MCID. We evaluated a total of 575 COPD patients with a mean age of 61.4 ± 9.2 years. 6MWT improved significantly, with a mean change of 32.3 ± 71.2. A total of 105/311 participants who had reached the MCID were still classified as "below average" by the T2D. Conversely, 76/264 patients who had not reached the MCID were classified as "above average". This new performance measure accounts for the patient's current status and for changes over time, potentially representing a simple and user-friendly tool that can be used to quantify a patient's performance and response to rehabilitation. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
43. Long COVID Citizen Scientists: Developing a Needs-Based Research Agenda by Persons Affected by Long COVID.
- Author
-
Ziegler, Sarah, Raineri, Alessia, Nittas, Vasileios, Rangelov, Natalie, Vollrath, Fabian, Britt, Chantal, and Puhan, Milo A.
- Published
- 2022
- Full Text
- View/download PDF
44. Preoperative smoking cessation program in patients undergoing intermediate to high-risk surgery: a randomized, single-blinded, controlled, superiority trial.
- Author
-
Fankhauser, Christian D., Affentranger, Andres, Cortonesi, Beatrice, Jeker, Urs, Gass, Markus, Minervini, Fabrizio, Jung, Georg, Christmann, Corina, Brambs, Christine, Puhan, Milo A., and Held, Ulrike
- Subjects
SMOKING cessation ,EVALUATION research ,NICOTINE ,MEDICAL care ,SMOKING ,RANDOMIZED controlled trials ,FERRANS & Powers Quality of Life Index ,QUALITY of life ,RESEARCH ,RESEARCH methodology ,COMPARATIVE studies ,IMPACT of Event Scale - Abstract
Background: At present, effectively implementing smoking cessation programs in the health care system constitutes a major challenge. A unique opportunity to initiate smoking cessation focuses on smokers scheduled for surgery. These patients are not only highly motivated to quit smoking but also likely to benefit from a reduction in postoperative complications which may translate into a decrease of costs. Nevertheless, surgical patients are not routinely informed about the benefits of preoperative smoking cessation. Potential reasons for this missed opportunity may be the lack of time and training of surgeons and anaesthesiologists. We therefore aim to analyse the impact of a preoperative high-intensity smoking cessation intervention on surgical complications up to a 90-day postoperative period in patients of various surgical disciplines. The hypothesis is that a preoperative smoking cessation program improves outcomes in smokers undergoing intermediate to high-risk surgery.Methods: The present study is a single-centre, randomized trial with two parallel groups of smokers scheduled for surgery comparing surgery alone and surgery with preoperative smoking cessation. We plan to randomize 251 patients. The primary objective is to compare complications between patients with an institutional multifaceted smoking cessation intervention starting 4 weeks before surgery compared to patients in the advice-only group (control group) within a 90-day postoperative period. The primary endpoint is the Comprehensive Complication Index (CCI®) within 90 days of surgery. Secondary outcomes include the length of hospital stay, cost of care, quality of life, smoking abstinence, and reduction in nicotine consumption.Discussion: The hypothesis is that a preoperative smoking cessation program improves outcomes in smokers undergoing surgery.Trial Registration: BASEC #2021-02004; ClinicalTrials.gov: NCT05192837 . Registered on January 14, 2022. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
45. Heterogenous humoral and cellular immune responses with distinct trajectories post-SARS-CoV-2 infection in a population-based cohort.
- Author
-
Menges, Dominik, Zens, Kyra D., Ballouz, Tala, Caduff, Nicole, Llanas-Cornejo, Daniel, Aschmann, Hélène E., Domenghino, Anja, Pellaton, Céline, Perreau, Matthieu, Fenwick, Craig, Pantaleo, Giuseppe, Kahlert, Christian R., Münz, Christian, Puhan, Milo A., and Fehr, Jan S.
- Subjects
SARS-CoV-2 Omicron variant ,SARS-CoV-2 Delta variant ,IMMUNOGLOBULINS ,LONGEVITY ,ANTIBODY formation ,CELLULAR immunity ,IMMUNE response ,T cells - Abstract
To better understand the development of SARS-CoV-2-specific immunity over time, a detailed evaluation of humoral and cellular responses is required. Here, we characterize anti-Spike (S) IgA and IgG in a representative population-based cohort of 431 SARS-CoV-2-infected individuals up to 217 days after diagnosis, demonstrating that 85% develop and maintain anti-S responses. In a subsample of 64 participants, we further assess anti-Nucleocapsid (N) IgG, neutralizing antibody activity, and T cell responses to Membrane (M), N, and S proteins. In contrast to S-specific antibody responses, anti-N IgG levels decline substantially over time and neutralizing activity toward Delta and Omicron variants is low to non-existent within just weeks of Wildtype SARS-CoV-2 infection. Virus-specific T cells are detectable in most participants, albeit more variable than antibody responses. Cluster analyses of the co-evolution of antibody and T cell responses within individuals identify five distinct trajectories characterized by specific immune patterns and clinical factors. These findings demonstrate the relevant heterogeneity in humoral and cellular immunity to SARS-CoV-2 while also identifying consistent patterns where antibody and T cell responses may work in a compensatory manner to provide protection. The persistence of the immune response to SARS-CoV-2 after recovery from infection is an indicator for subsequent protection against infection. Here the authors follow recovered patients and measure antibody and T cell responses and find that these two parts of the immune response may have different longevity. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
46. Functional immunity against SARS-CoV-2 in the general population after a booster campaign and the Delta and Omicron waves, Switzerland, March 2022.
- Author
-
Amati, Rebecca, Frei, Anja, Kaufmann, Marco, Sabatini, Serena, Pellaton, Céline, Fehr, Jan, Albanese, Emiliano, and Puhan, Milo A.
- Published
- 2022
- Full Text
- View/download PDF
47. TripletCough: Cougher Identification and Verification From Contact-Free Smartphone-Based Audio Recordings Using Metric Learning.
- Author
-
Jokic, Stefan, Cleres, David, Rassouli, Frank, Steurer-Stey, Claudia, Puhan, Milo A., Brutsche, Martin, Fleisch, Elgar, and Barata, Filipe
- Subjects
SOUND recordings ,SUPERVISED learning ,SMARTPHONES ,CONVOLUTIONAL neural networks ,IDENTIFICATION ,RESPIRATORY diseases ,DIAGNOSIS - Abstract
Cough, a symptom associated with many prevalent respiratory diseases, can serve as a potential biomarker for diagnosis and disease progression. Consequently, the development of cough monitoring systems and, in particular, automatic cough detection algorithms have been studied since the early 2000s. Recently, there has been an increased focus on the efficiency of such algorithms, as implementation on consumer-centric devices such as smartphones would provide a scalable and affordable solution for monitoring cough with contact-free sensors. Current algorithms, however, are incapable of discerning between coughs of different individuals and, thus, cannot function reliably in situations where potentially multiple individuals have to be monitored in shared environments. Therefore, we propose a weakly supervised metric learning approach for cougher recognition based on smartphone audio recordings of coughs. Our approach involves a triplet network architecture, which employs convolutional neural networks (CNNs). The CNNs of the triplet network learn an embedding function, which maps Mel spectrograms of cough recordings to an embedding space where they are more easily distinguishable. Using audio recordings of nocturnal coughs from asthmatic patients captured with a smartphone, our approach achieved a mean accuracyof 88 $\%$ ($\pm$ 10 $\%$ SD) on two-way identification tests with 12 enrollment samples and accuracy of 80 $\%$ and an equal error rate (EER) of 20 $\%$ on verification tests. Furthermore, our approach outperformed human raters with regard to verification tests on average by 8% in accuracy, 4% in false acceptance rate (FAR), and 12% in false rejection rate (FRR). Our code and models are publicly available. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
48. Patient Preference Studies for Advanced Prostate Cancer Treatment Along the Medical Product Life Cycle: Systematic Literature Review.
- Author
-
Menges, Dominik, Piatti, Michela C, Cerny, Thomas, and Puhan, Milo A
- Subjects
PATIENT preferences ,PRODUCT life cycle ,MEDICAL supplies ,PROSTATE cancer ,CANCER treatment - Abstract
Background: Patient preference studies can inform decision-making across all stages of the medical product life cycle (MPLC). The treatment landscape for advanced prostate cancer (APC) treatment has substantially changed in recent years. However, the most patient-relevant aspects of APC treatment remain unclear. This systematic review of patient preference studies in APC aimed to summarize the evidence on patient preferences and patient-relevant aspects of APC treatments, and to evaluate the potential contribution of existing studies to decision-making within the respective stages of the MPLC. Methods: We searched MEDLINE and EMBASE for studies evaluating patient preferences related to APC treatment up to October 2020. Two reviewers independently performed screening, data extraction and quality assessment in duplicate. We descriptively summarized the findings and analyzed the studies regarding their contribution within the MPLC using an analytical framework. Results: Seven quantitative preference studies were included. One study each was conducted in the marketing approval and the health technology assessment (HTA) and reimbursement stage, and five were conducted in the post-marketing stage of the MPLC. While almost all stated to inform clinical practice, the specific contributions to clinical decision-making remained unclear for almost all studies. Evaluated attributes related to benefits, harms, and other treatment-related aspects and their relative importance varied relevantly between studies. All studies were judged of high quality overall, but some methodological issues regarding sample selection and the definition of patient-relevant treatment attributes were identified. Conclusion: The most patient-relevant aspects regarding the benefits and harms of APC treatment are not yet established, and it remains unclear which APC treatments are preferred by patients. Findings from this study highlight the importance of transparent reporting and discussion of study findings according to their aims and with respect to their stage within the MPLC. Future research may benefit from using the MPLC framework for analyzing or determining the aims and design of patient preference studies. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
49. Effectiveness of a tailored web app on sun protection intentions and its implications for skin cancer prevention: A randomized controlled trial.
- Author
-
Nittas, Vasileios, Mütsch, Margot, Frey, Tobias, Braun, Julia, and Puhan, Milo A.
- Published
- 2022
- Full Text
- View/download PDF
50. Individual-Level Evaluation of the Exposure Notification Cascade in the SwissCovid Digital Proximity Tracing App: Observational Study.
- Author
-
Ballouz, Tala, Menges, Dominik, Aschmann, Hélène E., Ruedi Jung, Domenghino, Anja, Fehr, Jan S., Puhan, Milo A., and von Wyl, Viktor
- Published
- 2022
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.